Losartan Potassium Tablet, Film Coated
Product Images NDC 55154-2089

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 55154-2089). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7c74ee11 5813 39cd E053 2a91aa0a5d6c

Losartan Potassium oral film-coated tablets in white, oval shape. One tablet is embossed with the number '2' and the other with the letter 'Z'. The image includes a millimeter scale indicating approximate tablet size. No strength or manufacturer markings are visible on the tablets.*

FDA Label Image

7c74ee11 5814 39cd E053 2a91aa0a5d6c

Losartan Potassium 100 mg film-coated oral tablet imprinted with 'Z 16' on one side and plain on the other. The white, oblong tablet is shown against a gray background with a millimeter scale for size reference. Labeler: Cardinal Health 107, LLC.*

FDA Label Image

7c74f89a 87e8 1073 E053 2991aa0ae062

Losartan Potassium 100 mg film-coated tablet, oval white with imprint "Z 18" on one side and plain on the other. The tablet measures approximately 12 mm in length. This oral prescription drug is labeled by Cardinal Health 107, LLC.*

FDA Label Image

883ed688 Efe0 4aa1 B10f E658bd32b498 02

A line graph comparing the percentage of patients with primary endpoint events over time in months for Atenolol (dashed line) and Losartan Potassium (solid line). The graph shows cumulative data up to 66 months, with an adjusted risk reduction of 13% (p=0.021) favoring Losartan Potassium.*

FDA Label Image

883ed688 Efe0 4aa1 B10f E658bd32b498 03

A line graph comparing the percentage of patients with fatal or non-fatal stroke over a 66-month study period for two drugs: Atenolol (dashed line) and Losartan Potassium (solid line). The graph illustrates an adjusted risk reduction of 25% for Losartan Potassium with a p-value of 0.001.*

FDA Label Image

883ed688 Efe0 4aa1 B10f E658bd32b498 04

A clinical outcome forest plot comparing Losartan Potassium (Losartan-K) and Atenolol across several patient subgroups. The chart shows hazard ratios with 95% confidence intervals for both a primary composite endpoint and stroke (fatal/non-fatal). Subgroups include age, gender, race, ischemic heart disease (ISH), diabetes, and history of cardiovascular disease (CVD). The plot visually indicates favorability toward either Losartan-K or Atenolol based on hazard ratios.*

FDA Label Image

883ed688 Efe0 4aa1 B10f E658bd32b498 05

A line graph comparing the percentage of patients with events over 48 months between Losartan Potassium Tablet and placebo groups. The graph shows a lower event rate for Losartan Potassium, with a noted risk reduction of 16.1% and a p-value of 0.022.*

FDA Label Image

98405be3 794d Ccf9 E053 2995a90a537e 00

Losartan Potassium Tablets USP 100 mg film-coated tablet unit dose packaging containing 10 tablets. Label includes storage instructions (20° to 25°C), dosage reference, warnings about child resistance and institutional use, and pharmacist dispensing instructions. Distributed by Cardinal Health and packaged by American Health Packaging.*

FDA Label Image

98405be3 794d Ccf9 E053 2995a90a537e 01

Losartan Potassium Tablets, USP 50 mg film-coated tablets in a package of 10 tablets. The label includes storage instructions to keep between 20° to 25°C with permitted excursions, and warnings about child resistance and institutional use. The product is distributed by Cardinal Health, Dublin, OH, and packaged by American Health Packaging.*

FDA Label Image

98405be3 794d Ccf9 E053 2995a90a537e 02

Losartan Potassium Tablets USP 25 mg film-coated tablet label containing 10 tablets. Includes storage instructions, prescription status (RX only), and warnings about child resistance and outpatient container use. Packaged and distributed by American Health Packaging and Cardinal Health, listing NDC 55154-4783-0 with additional information about the product origin and handling.*

FDA Label Image

Losartan Potassium Structural Formula (Image 01)

Chemical structure diagram of losartan potassium, illustrating the molecular composition and arrangement of the active ingredient in the drug.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.